Recently, some researchers have extended the study of the APOE impact to other conditions, such as cardiovascular diseases (Abondio et al., 2023), traumatic brain injury (Lawrence et al., 2015), multiple sclerosis (Naseri et al., 2022) and temporal lobe epilepsy. The gene discussed is APOE; the disease is temporal lobe epilepsy.